Personalis, Inc., headquartered in Fremont, CA, specializes in personalizing precision oncology through advanced genomic and immune profiling technologies. The company focuses on immuno-oncology, immuno-genomics, biomarkers, and tumor microenvironment analysis to support cancer diagnostics and therapeutics. Personalis leverages exome and transcriptome data to enhance precision medicine approaches in oncology.

‌